Case number 2022-2276
Sumitomo Pharma Co., Ltd. v. Vidal > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 28, 2024 | 48 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [1006738] [MVH] [Entered: 05/28/2024 11:30 AM] (1) |
| Apr 7, 2024 | 0 | SUMITOMO PHARMA CO., LTD. v. VIDAL [OPINION] [nonprecedential] (0) |
| Apr 5, 2024 | 47 | JUDGMENT. VACATED AND REMANDED. Terminated on the merits after oral argument. COSTS: Each Side Bears Its Own Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [995360] [MVH] [Entered: 04/05/2024 08:49 AM] (1) |
| Apr 5, 2024 | 46 | OPINION filed for the court by Taranto, Circuit Judge; Hughes, Circuit Judge and Cunningham, Circuit Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [995359] [MVH] [Entered: 04/05/2024 08:49 AM] (7) |
| Mar 7, 2024 | 45 | Submitted after ORAL ARGUMENT to Panel: Taranto, Circuit Judge; Hughes, Circuit Judge and Cunningham, Circuit Judge.Arguing counsel: Thomas Saunders for Sumitomo Pharma Co., Ltd. and Mary L. Kelly for Katherine K. Vidal.Oral Argument Audio available here. [989189] [MJL] [Entered: 03/07/2024 04:01 PM] (0) |
| Feb 1, 2024 | 44 | Response to notice of oral argument from Intervenor Katherine K. Vidal. Service: 02/01/2024 by email. [980886] [22-2276] [Mary Kelly] [Entered: 02/01/2024 07:22 AM] (1) |
| Jan 31, 2024 | 43 | Response to notice of oral argument from Appellant Sumitomo Pharma Co., Ltd.. Service: 01/31/2024 by email. [980743] [22-2276] [Thomas Saunders] [Entered: 01/31/2024 01:28 PM] (1) |
| Jan 22, 2024 | 42 | NOTICE OF ORAL ARGUMENT. Panel: 2403J. Case scheduled March 7, 2024. Response to Notice of Oral Argument due: 02/05/2024. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [978257] [MVH] [Entered: 01/22/2024 03:59 PM] (2) |
| Jan 22, 2024 | 41 | The following conflict dates submitted by Mary L. Kelly for Katherine K. Vidal have been accepted by the court: 04/01/2024, 04/02/2024, 04/03/2024, 04/04/2024, 04/05/2024, 06/03/2024, 06/04/2024, 06/05/2024, 06/06/2024, 06/07/2024. [977984] [MJL] [Entered: 01/22/2024 09:24 AM] (0) |
| Jan 22, 2024 | 40 | Notice from Intervenor Katherine K. Vidal regarding conflicts with oral argument. Service: 01/22/2024 by email. [977966] [22-2276] [Mary Kelly] [Entered: 01/22/2024 08:04 AM] (3) |
| Jan 2, 2024 | 39 | Notice from Appellant Sumitomo Pharma Co., Ltd. regarding conflicts with oral argument. Service: 01/02/2024 by email. [974001] [22-2276] [Thomas Saunders] [Entered: 01/02/2024 12:59 PM] (4) |
| Dec 28, 2023 | 38 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [973501] [MMA] [Entered: 12/28/2023 04:45 PM] (1) |
| Oct 31, 2023 | 37 | Notice from Intervenor Katherine K. Vidal of Withdrawal of Director's Counsel (Thomas W. Krause). Service: 10/31/2023 by email. [960213] [22-2276] [Farheena Rasheed] [Entered: 10/31/2023 06:45 AM] (1) |
| Aug 2, 2023 | 36 | The following conflict dates submitted by Thomas Saunders for Sumitomo Pharma Co., Ltd. have been accepted by the court: 03/04/2024, 03/05/2024, 03/06/2024, 03/07/2024, 03/08/2024. [940204] [MJL] [Entered: 08/02/2023 02:34 PM] (0) |
| Aug 2, 2023 | 35 | Notice from Appellant Sumitomo Pharma Co., Ltd. regarding conflicts with oral argument. Service: 08/02/2023 by email. [940158] [22-2276] [Thomas Saunders] [Entered: 08/02/2023 01:47 PM] (4) |
| Jul 13, 2023 | 34 | 6 paper copies of Doc. No. [19] received from Intervenor Katherine K. Vidal. [936206] [VDW] [Entered: 07/13/2023 04:11 PM] (0) |
| Jul 13, 2023 | 33 | 6 paper copies of Doc. No. [24], [23], [16] received from Appellant Sumitomo Pharma Co., Ltd.. [936178] [VDW] [Entered: 07/13/2023 03:28 PM] (0) |
| Jul 13, 2023 | 32 | Notice from Appellant Sumitomo Pharma Co., Ltd. regarding conflicts with oral argument. Service: 07/13/2023 by email. [936088] [22-2276] [John Dragseth] [Entered: 07/13/2023 01:20 PM] (2) |
| Jul 13, 2023 | 31 | The following conflict dates submitted by Mary L. Kelly for Katherine K. Vidal have been accepted by the court: 11/06/2023, 11/07/2023, 11/08/2023, 11/09/2023. [936037] [MJL] [Entered: 07/13/2023 11:22 AM] (0) |
| Jul 13, 2023 | 30 | Notice from Intervenor Katherine K. Vidal regarding conflicts with oral argument. Service: 07/13/2023 by email. [935942] [22-2276] [Mary Kelly] [Entered: 07/13/2023 07:12 AM] (3) |
| Jul 11, 2023 | 29 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [935300] [MMA] [Entered: 07/11/2023 10:19 AM] (1) |
| Jul 11, 2023 | 28 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [935295] [MMA] [Entered: 07/11/2023 10:06 AM] (0) |
| Jul 7, 2023 | 27 | Notice from Appellant Sumitomo Pharma Co., Ltd. of Withdrawal of W. Chad Shear as Non-Principal Counsel.. Service: 07/07/2023 by email. [934777] [22-2276] [Nitika Gupta Fiorella] [Entered: 07/07/2023 02:47 PM] (6) |
| Jun 29, 2023 | 24 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellant Sumitomo Pharma Co., Ltd. Service: 06/29/2023 by email. [933363]--[Edited 07/10/2023 by MMA - Reason: compliance review complete] [Nitika Gupta Fiorella] [Entered: 06/29/2023 09:06 PM] (0) |
| Jun 29, 2023 | 25 | MODIFIED ENTRY: APPENDIX FILED by Appellant Sumitomo Pharma Co., Ltd. Service: 06/29/2023 by email. [933365]--[Edited 07/10/2023 by MMA - Reason: compliance review complete] [Nitika Gupta Fiorella] [Entered: 06/29/2023 09:11 PM] (666) |
| Jun 29, 2023 | 26 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant Sumitomo Pharma Co., Ltd.. Service: 06/29/2023 by email. [933366] [22-2276] [Nitika Gupta Fiorella] [Entered: 06/29/2023 09:14 PM] (5) |
| Jun 22, 2023 | 23 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Sumitomo Pharma Co., Ltd. Service: 06/23/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [931792] --[Edited 06/30/2023 by ALK - compliance review complete] [John Dragseth] [Entered: 06/22/2023 06:50 PM] (42) |
| Jun 22, 2023 | 22 | Amended Certificate of Interest for Appellant Sumitomo Pharma Co., Ltd.. Service: 06/22/2023 by email. [931791] [22-2276] [John Dragseth] [Entered: 06/22/2023 06:48 PM] (3) |
| May 12, 2023 | 21 | **TEXT ONLY** ORDER granting motion to extend time to file brief [20] filed by Appellant Sumitomo Pharma Co., Ltd. The reply brief is due 06/23/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [922983] [MMA] [Entered: 05/12/2023 08:56 AM] (0) |
| May 10, 2023 | 20 | MOTION of Appellant Sumitomo Pharma Co., Ltd. to extend the time to 06/23/2023 to file brief. Service: 05/10/2023 by email. [922622] [22-2276] [John Dragseth] [Entered: 05/10/2023 03:40 PM] (8) |
| May 3, 2023 | 19 | MODIFIED ENTRY: INTERVENOR BRIEF FILED by Intervenor Katherine K. Vidal. Service: 05/03/2023 by email. [921018]--[Edited 05/12/2023 by MMA - Reason: compliance review complete] [Mary Kelly] [Entered: 05/03/2023 11:18 PM] (58) |
| Apr 7, 2023 | 18 | **TEXT ONLY** ORDER granting motion to extend time to file brief [17] filed by Intervenor Katherine K. Vidal. The intervenor brief is due 05/03/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [915375] [MMA] [Entered: 04/07/2023 02:50 PM] (0) |
| Apr 4, 2023 | 17 | MOTION of Intervenor Katherine K. Vidal to extend the time to 05/03/2023 to file brief. Service: 04/04/2023 by email. [914171] [22-2276] [Mary Kelly] [Entered: 04/04/2023 09:09 AM] (3) |
| Mar 10, 2023 | 16 | MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED by Appellant Sumitomo Pharma Co., Ltd. Service: 03/10/2023 by email. [909318]--[Edited 03/21/2023 by MMA - Reason: compliance review complete] [John Dragseth] [Entered: 03/10/2023 08:05 PM] (0) |
| Mar 10, 2023 | 15 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Sumitomo Pharma Co., Ltd. Service: 03/10/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [909317]--[Edited 03/21/2023 by MMA - Reason: compliance review complete] [John Dragseth] [Entered: 03/10/2023 08:00 PM] (139) |
| Mar 7, 2023 | 14 | Entry of Appearance for Thomas G. Saunders; Emily R. Whelan as counsel for Appellant Sumitomo Pharma Co., Ltd.. Service: 03/07/2023 by email. [908428] [22-2276] [Thomas Saunders] [Entered: 03/07/2023 04:46 PM] (2) |
| Feb 15, 2023 | 13 | Entry of Appearance for Mai-Trang D. Dang as counsel for Intervenor Katherine K. Vidal. Service: 02/15/2023 by email. [904432] [22-2276] [Mai-Trang Dang] [Entered: 02/15/2023 02:37 PM] (1) |
| Jan 12, 2023 | 12 | Docketing Statement for the Intervenor Katherine K. Vidal. Service: 01/12/2023 by email. [896469] [22-2276] [Mary Kelly] [Entered: 01/12/2023 08:31 AM] (2) |
| Jan 3, 2023 | 11 | ORDER The revised official caption and revised short caption are reflected herein. The intervenor is directed to file a docketing statement no later than 14 days from the date of filing of this order. The motion for extension of time [8] is granted. The opening brief is due 03/10/2023. Service as of this date by the Clerk of Court. [894085] [LMS] [Entered: 01/03/2023 10:33 AM] (2) |
| Dec 15, 2022 | 10 | Entry of Appearance for Mary L. Kelly; Thomas W. Krause; Farheena Y. Rasheed; Peter J. Ayers; Kakoli Caprihan as counsel for Katherine K. Vidal, Director, U.S. Patent and Trademark Office. Service: 12/15/2022 by email. [890772] [22-2276] [Mary Kelly] [Entered: 12/15/2022 08:57 AM] (2) |
| Dec 15, 2022 | 9 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 12/15/2022 by email. [890771] [22-2276] [Mary Kelly] [Entered: 12/15/2022 08:53 AM] (2) |
| Dec 9, 2022 | 8 | MOTION of Appellant Sumitomo Pharma Co., Ltd. to extend the time to 03/10/2023 to file brief. Service: 12/09/2022 by email. [889683] [22-2276] [John Dragseth] [Entered: 12/09/2022 02:17 PM] (7) |
| Nov 16, 2022 | 7 | ORDER filed modifying the official caption. The revised official caption and short caption are reflected in this order. Within 30 days of the date of filing of this order, the Director of the United States Patent and Trademark Office is directed to inform this court whether she intends to intervene in this appeal. (see order for further details) Service as of this date by the Clerk of Court. [884476] [LMS] [Entered: 11/16/2022 02:20 PM] (2) |
| Nov 9, 2022 | 6 | Certified list received. Service: 11/08/2022 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [883224] [MMA] [Entered: 11/09/2022 03:13 PM] (62) |
| Oct 13, 2022 | 5 | Certificate of Interest for Appellant Sumitomo Pharma Co., Ltd.. Service: 10/13/2022 by email. [877624] [22-2276] [Nitika Gupta Fiorella] [Entered: 10/13/2022 01:15 PM] (3) |
| Oct 13, 2022 | 4 | Docketing Statement for the Appellant Sumitomo Pharma Co., Ltd.. Service: 10/13/2022 by email. [877623] [22-2276] [Nitika Gupta Fiorella] [Entered: 10/13/2022 01:13 PM] (2) |
| Oct 13, 2022 | 3 | Entry of appearance for Nitika Gupta Fiorella; W. Chad Shear; Michael J. Kane; John A. Dragseth; Tim J. Rawson; Sarah E. Jack as counsel for Appellant Sumitomo Pharma Co., Ltd.. Service: 10/13/2022 by email. [877622] [22-2276] [Nitika Gupta Fiorella] [Entered: 10/13/2022 01:12 PM] (2) |
| Oct 12, 2022 | 2 | Notice from Appellee Slayback Pharma LLC of Non-Appearance. Service: 10/12/2022 by email. [877281] [22-2276] [Louis Weinstein] [Entered: 10/12/2022 02:06 PM] (1) |
| Sep 29, 2022 | 1 | Appeal docketed. Received: 09/26/2022. [874713] Entry of Appearance due 10/13/2022. Certificate of Interest is due on 10/13/2022. Docketing Statement due 10/13/2022. Certified List due on 11/08/2022. [MMA] [Entered: 09/29/2022 11:48 AM] (0) |
